Biogen Buys Apellis for $5.6B to Expand Kidney DrugsBloomberg1 Apr 2026Duration: 1:46Read the full storyUp nextWhy Singapore Stocks Keep Hitting Record HighSri Lankan Inflation to Come Down: Central Bank HeadTrump Says He's Curtailing Drills With South KoreaSri Lanka Central Bank: Inflation to Come DownFed's Internal Rate Debate Faces New ScrutinyInside the Business of Ultra Luxury Travel